Filing Details

Accession Number:
0000884905-16-000183
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 09:06:52
Reporting Period:
2016-11-09
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 09:06:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884905 Praxair Inc PX Industrial Inorganic Chemicals (2810) 061249050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190775 F Stephen Angel C/O Praxair, Inc.
39 Old Ridgebury Road
Danbury CT 06810-5113
Chairman, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-09 83,300 $61.47 120,689 No 4 M Direct
Common Stock Disposition 2016-11-09 83,300 $119.04 37,389 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-11-09 83,300 $0.00 83,300 $61.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-02-27 2017-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,268 Indirect In trust for children
Common Stock 173,649 Indirect Grantor Retained Annuity Trusts
Common Stock 13,164 Indirect Angel Descendants Trust
Common Stock 8,635 Indirect 401(k)
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $83.89 2009-02-26 2018-02-26 195,200 195,200 Direct
Common Stock Stock Option (right to buy) $60.92 2010-02-24 2019-02-24 281,510 281,510 Direct
Common Stock Stock Option (right to buy) $76.16 2011-02-23 2020-02-23 204,640 204,640 Direct
Common Stock Stock Option (right to buy) $97.84 2012-02-22 2021-02-22 218,175 218,175 Direct
Common Stock Stock Option (right to buy) $109.68 2013-02-28 2022-02-28 236,510 236,510 Direct
Common Stock Stock Option (right to buy) $110.58 2014-02-26 2023-02-26 187,015 187,015 Direct
Common Stock Stock Option (right to buy) $128.80 2015-02-25 2024-02-25 203,930 203,930 Direct
Common Stock Stock Option (right to buy) $128.38 2016-02-24 2025-02-24 261,075 261,075 Direct
Common Stock Stock Option (right to buy) $102.22 2017-02-23 2026-02-23 416,355 416,355 Direct
Common Stock Deferred Stock Unit $0.00 64,729 64,729 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-26 195,200 195,200 Direct
2019-02-24 281,510 281,510 Direct
2020-02-23 204,640 204,640 Direct
2021-02-22 218,175 218,175 Direct
2022-02-28 236,510 236,510 Direct
2023-02-26 187,015 187,015 Direct
2024-02-25 203,930 203,930 Direct
2025-02-24 261,075 261,075 Direct
2026-02-23 416,355 416,355 Direct
64,729 64,729 Direct
Footnotes
  1. The $119.037 price reported is the weighted average sale price. The sale prices ranged from $119.00 to $119.362 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  3. This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
  4. This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
  5. This option vests over three years in three consecutive equal annual installments beginning on February 24, 2016.
  6. The option vests over three years in three consecutivve equal annual installments beginning on February 23, 2017.
  7. Conversion to Praxair Common Stock is on a 1-for-1 basis.
  8. Deferred stock units acquired under the Praxair Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock.